Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Maestro

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
The American Journal of Pathology|April 23, 2003
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosisMarco Chilosi, Venerino Poletti, Alberto Zamò, et al.
Cell Death and Differentiation|April 19, 2018
A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressivenessAlessandra di Gennaro, Valentina Damiano, Giulia Brisotto, et al.
Hematological Oncology|October 27, 2016
Low-dose radiotherapy in diffuse large B-cell lymphomaCarlo Furlan, Vincenzo Canzonieri, Michele Spina, et al.
NPJ Precision Oncology|January 20, 2026
KIT Mutation-NTRK fusion oncogenic driver switch: a novel mechanism of acquired imatinib resistance in GISTSimona Gloazzo, Marta Sbaraglia, Elena Bellan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2008
Multiple primary sporadic gastrointestinal stromal tumors in the adult: an underestimated entityDaniela Gasparotto, Sabrina Rossi, Italo Bearzi, et al.
Cancer Cell|September 15, 2012
A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradationSara Piccinin, Elena Tonin, Sara Sessa, et al.
International Journal of Cancer|August 7, 2012
MUTYH c.933+3A>C, associated with a severely impaired gene expression, is the first Italian founder mutation in MUTYH-Associated PolyposisElisa Pin, Chiara Pastrello, Rossella Tricarico, et al.
Seminars in Oncology|August 12, 2009
Other targetable sarcomasVeridiana Pires de Camargo, Matt van de Rijn, Roberta Maestro, et al.
Oncotarget|June 16, 2016
Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumoursRosalin D Spagnuolo, Silvia Brich, Fabio Bozzi, et al.
Stem Cells (Dayton, Ohio)|February 3, 2015
miR-135a Inhibits Cancer Stem Cell-Driven Medulloblastoma Development by Directly Repressing Arhgef6 ExpressionKatayoun Hemmesi, Mario Leonardo Squadrito, Pieter Mestdagh, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
The American Journal of Pathology|April 23, 2003
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosisMarco Chilosi, Venerino Poletti, Alberto Zamò, et al.
Cell Death and Differentiation|April 19, 2018
A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressivenessAlessandra di Gennaro, Valentina Damiano, Giulia Brisotto, et al.
Hematological Oncology|October 27, 2016
Low-dose radiotherapy in diffuse large B-cell lymphomaCarlo Furlan, Vincenzo Canzonieri, Michele Spina, et al.
NPJ Precision Oncology|January 20, 2026
KIT Mutation-NTRK fusion oncogenic driver switch: a novel mechanism of acquired imatinib resistance in GISTSimona Gloazzo, Marta Sbaraglia, Elena Bellan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2008
Multiple primary sporadic gastrointestinal stromal tumors in the adult: an underestimated entityDaniela Gasparotto, Sabrina Rossi, Italo Bearzi, et al.
Cancer Cell|September 15, 2012
A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradationSara Piccinin, Elena Tonin, Sara Sessa, et al.
International Journal of Cancer|August 7, 2012
MUTYH c.933+3A>C, associated with a severely impaired gene expression, is the first Italian founder mutation in MUTYH-Associated PolyposisElisa Pin, Chiara Pastrello, Rossella Tricarico, et al.
Seminars in Oncology|August 12, 2009
Other targetable sarcomasVeridiana Pires de Camargo, Matt van de Rijn, Roberta Maestro, et al.
Oncotarget|June 16, 2016
Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumoursRosalin D Spagnuolo, Silvia Brich, Fabio Bozzi, et al.
Stem Cells (Dayton, Ohio)|February 3, 2015
miR-135a Inhibits Cancer Stem Cell-Driven Medulloblastoma Development by Directly Repressing Arhgef6 ExpressionKatayoun Hemmesi, Mario Leonardo Squadrito, Pieter Mestdagh, et al.
Pageof 11